n(omega)-hydroxyarginine has been researched along with Autoimmune Diabetes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagi, Z; Beleznai, T; Feher, A; Lansman, SL; Spielvogel, D | 1 |
1 other study(ies) available for n(omega)-hydroxyarginine and Autoimmune Diabetes
| Article | Year |
|---|---|
Arginase 1 contributes to diminished coronary arteriolar dilation in patients with diabetes.
Topics: Acetylcholine; Aged; Arginase; Arginine; Arterioles; Coronary Vessels; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; NG-Nitroarginine Methyl Ester; Nitroprusside; Up-Regulation; Vasodilation; Vasodilator Agents | 2011 |